-Cancer Outcomes (CO) Shared Resource The Cancer Outcomes (CO) Shared Resource is a new resource to support a large and highly productive group of cancer center faculty conducting population science big data research, including analyses of linked cancer registry/insurance claims datasets; epidemiologic cohort studies; registries; and other real-world clinical data sources. The CO provides three main services: 1) development and support of a North Carolina multi- payer linked dataset; 2) methodological consulting services for population science big data analyses; and 3) software/systems development for managing real-world clinical data. By collaborating with the North Carolina Central Cancer Registry and other data partners, this unique North Carolina dataset represents the entire state?s cancer population (>400,000 patients) as well as 5.5 million unique beneficiaries in Medicare, Medicaid, and private insurance plans. This rich and unprecedented state-level resource represents heterogeneous populations which are often not represented in clinical trials. This shared resource directly addresses the emerging need of population science to develop big data infrastructure and methods. Research supported by the CO can directly answer crucial questions in cancer care related to access, disparities, quality, technology diffusion, guideline adherence, and cost of cancer care. The differential impact of insurance coverage models and policy initiatives can also be evaluated at the population, provider, and patient levels. Through an interdisciplinary ?team science? approach, the Cancer Outcomes Shared Resource has developed novel data linkages, systems, and methods that allow researchers to better leverage the power of big data to improve population health. By partnering closely with computer scientists and research methodologists the CO team has developed extensive tools and web systems which make these big datasets interoperable and support the entire research lifecycle from hypothesis generation through manuscript publication. Supported by Cancer Center funds since its inception in 2012, this shared resource is already a highly used and successful resource: CO staff has worked with 36 faculty members, enabled publication of 41 manuscripts in peer- reviewed journals and nearly $10 million in funding from private and public sources external to UNC. Funds are proposed to support salary for key staff members and annual data updates

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-44
Application #
9834863
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Shen, Hui; Shih, Juliann; Hollern, Daniel P et al. (2018) Integrated Molecular Characterization of Testicular Germ Cell Tumors. Cell Rep 23:3392-3406
Shao, Wenwei; Chen, Xiaojing; Samulski, Richard J et al. (2018) Inhibition of antigen presentation during AAV gene therapy using virus peptides. Hum Mol Genet 27:601-613
Gao, Yanzhe; Kardos, Jordan; Yang, Yang et al. (2018) The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells. Sci Rep 8:15304
Schaefer, Kristina N; Bonello, Teresa T; Zhang, Shiping et al. (2018) Supramolecular assembly of the beta-catenin destruction complex and the effect of Wnt signaling on its localization, molecular size, and activity in vivo. PLoS Genet 14:e1007339
Zuze, Takondwa; Painschab, Matthew S; Seguin, Ryan et al. (2018) Plasmablastic lymphoma in Malawi. Infect Agent Cancer 13:22
Wang, Jeremy R; Holt, James; McMillan, Leonard et al. (2018) FMLRC: Hybrid long read error correction using an FM-index. BMC Bioinformatics 19:50
Lee, Janie M; Abraham, Linn; Lam, Diana L et al. (2018) Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography. J Clin Oncol 36:2070-2077
Thomas, Nancy E; Edmiston, Sharon N; Orlow, Irene et al. (2018) Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes. J Invest Dermatol 138:2398-2404
Cousins, Emily M; Goldfarb, Dennis; Yan, Feng et al. (2018) Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3? and Activates WNT Signaling. Mol Cancer Res 16:333-344
Armstrong, Robin L; Penke, Taylor J R; Strahl, Brian D et al. (2018) Chromatin conformation and transcriptional activity are permissive regulators of DNA replication initiation in Drosophila. Genome Res 28:1688-1700

Showing the most recent 10 out of 1525 publications